References
M.Z. Atassi, P.R. Deitiker, Does Clostridium botulinum neurotoxin a exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons? Endocrine (2011). doi:10.1007/s12020-011-9481-2
D.M. Gross, T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z.A. Nagy, J.A. Field, A.C. Steere, B.T. Huber, Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281, 703–706 (1998)
H. Bigalke, D. Dressler, J. Frevert, Immunological properties of botulinum toxins, in Manual of Botulinum Toxin Therapy, ed. by D. Truong, D. Dressler, M. Hallett (Cambridge University Press, Cambridge, 2009), pp. 23–28
S.G.E. Marsh, P. Parham, L.D. Barber, The HLA FactsBook (Academic Press, London, 2000)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gregoric, E., Gregoric, J.A., Guarneri, F. et al. Reply: Does Clostridium botulinum neurotoxin A exhibit molecular mimicry with thyroid autoantigens and cause thyroid complications in predisposed persons?. Endocrine 40, 142–143 (2011). https://doi.org/10.1007/s12020-011-9484-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9484-z